Determination of glucose-6-phosphate dehydrogenase cut-off values in a Tunisian population

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the commonest enzymopathy worldwide. The incidence depends essentially on the methods used for the assessment. In this respect, we attempted in this study to set cut-off values of G6PD activity to discriminate among normal, heterozygous, and def...

Full description

Saved in:
Bibliographic Details
Published inClinical chemistry and laboratory medicine Vol. 55; no. 8; pp. 1193 - 1201
Main Authors Laouini, Naouel, Sahli, Chaima Abdelhafidh, Jouini, Latifa, Haloui, Sabrine, Fredj, Sondes Hadj, Daboubi, Rym, Siala, Hajer, Ouali, Faida, Becher, Meriam, Toumi, Nourelhouda, Bibi, Amina, Messsaoud, Taieb
Format Journal Article
LanguageEnglish
Published Germany De Gruyter 26.07.2017
Walter De Gruyter & Company
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the commonest enzymopathy worldwide. The incidence depends essentially on the methods used for the assessment. In this respect, we attempted in this study to set cut-off values of G6PD activity to discriminate among normal, heterozygous, and deficient individuals using the World Health Organization (WHO) classification and the receiver operating characteristics (ROC) curve analysis. Blood samples from 250 female and 302 male subjects were enrolled in this study. The G6PD activity was determined using a quantitative assay. The common G6PD mutations in Tunisia were determined using the amplification refractory mutation system (ARMS-PCR) method. The ROC curve was used to choice the best cut-off. Normal G6PD values were 7.69±2.37, 7.86±2.39, and 7.51±2.35 U/g Hb for the entire, male, and female groups, respectively. Cut-off values for the total, male, and female were determined using the WHO classification and ROC curves analysis. In the male population, both cut-offs established using ROC curve analysis (4.00 U/g Hb) and the 60% level (3.82 U/g Hb), respectively are sensitive and specific resulting in a good efficiency of discrimination between deficient and normal males. For the female group the ROC cut-off (5.84 U/g Hb) seems better than the 60% level cut-off (3.88 U/g Hb) to discriminate between normal and heterozygote or homozygote women with higher Youden Index. The establishment of the normal values for a population is important for a better evaluation of the assay result. The ROC curve analysis is an alternative method to determine the status of patients since it correlates DNA analysis and G6PD activity.
AbstractList Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the commonest enzymopathy worldwide. The incidence depends essentially on the methods used for the assessment. In this respect, we attempted in this study to set cut-off values of G6PD activity to discriminate among normal, heterozygous, and deficient individuals using the World Health Organization (WHO) classification and the receiver operating characteristics (ROC) curve analysis. Blood samples from 250 female and 302 male subjects were enrolled in this study. The G6PD activity was determined using a quantitative assay. The common G6PD mutations in Tunisia were determined using the amplification refractory mutation system (ARMS-PCR) method. The ROC curve was used to choice the best cut-off. Normal G6PD values were 7.69±2.37, 7.86±2.39, and 7.51±2.35 U/g Hb for the entire, male, and female groups, respectively. Cut-off values for the total, male, and female were determined using the WHO classification and ROC curves analysis. In the male population, both cut-offs established using ROC curve analysis (4.00 U/g Hb) and the 60% level (3.82 U/g Hb), respectively are sensitive and specific resulting in a good efficiency of discrimination between deficient and normal males. For the female group the ROC cut-off (5.84 U/g Hb) seems better than the 60% level cut-off (3.88 U/g Hb) to discriminate between normal and heterozygote or homozygote women with higher Youden Index. The establishment of the normal values for a population is important for a better evaluation of the assay result. The ROC curve analysis is an alternative method to determine the status of patients since it correlates DNA analysis and G6PD activity.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the commonest enzymopathy worldwide. The incidence depends essentially on the methods used for the assessment. In this respect, we attempted in this study to set cut-off values of G6PD activity to discriminate among normal, heterozygous, and deficient individuals using the World Health Organization (WHO) classification and the receiver operating characteristics (ROC) curve analysis.BACKGROUNDGlucose-6-phosphate dehydrogenase (G6PD) deficiency is the commonest enzymopathy worldwide. The incidence depends essentially on the methods used for the assessment. In this respect, we attempted in this study to set cut-off values of G6PD activity to discriminate among normal, heterozygous, and deficient individuals using the World Health Organization (WHO) classification and the receiver operating characteristics (ROC) curve analysis.Blood samples from 250 female and 302 male subjects were enrolled in this study. The G6PD activity was determined using a quantitative assay. The common G6PD mutations in Tunisia were determined using the amplification refractory mutation system (ARMS-PCR) method. The ROC curve was used to choice the best cut-off.METHODSBlood samples from 250 female and 302 male subjects were enrolled in this study. The G6PD activity was determined using a quantitative assay. The common G6PD mutations in Tunisia were determined using the amplification refractory mutation system (ARMS-PCR) method. The ROC curve was used to choice the best cut-off.Normal G6PD values were 7.69±2.37, 7.86±2.39, and 7.51±2.35 U/g Hb for the entire, male, and female groups, respectively. Cut-off values for the total, male, and female were determined using the WHO classification and ROC curves analysis. In the male population, both cut-offs established using ROC curve analysis (4.00 U/g Hb) and the 60% level (3.82 U/g Hb), respectively are sensitive and specific resulting in a good efficiency of discrimination between deficient and normal males. For the female group the ROC cut-off (5.84 U/g Hb) seems better than the 60% level cut-off (3.88 U/g Hb) to discriminate between normal and heterozygote or homozygote women with higher Youden Index.RESULTSNormal G6PD values were 7.69±2.37, 7.86±2.39, and 7.51±2.35 U/g Hb for the entire, male, and female groups, respectively. Cut-off values for the total, male, and female were determined using the WHO classification and ROC curves analysis. In the male population, both cut-offs established using ROC curve analysis (4.00 U/g Hb) and the 60% level (3.82 U/g Hb), respectively are sensitive and specific resulting in a good efficiency of discrimination between deficient and normal males. For the female group the ROC cut-off (5.84 U/g Hb) seems better than the 60% level cut-off (3.88 U/g Hb) to discriminate between normal and heterozygote or homozygote women with higher Youden Index.The establishment of the normal values for a population is important for a better evaluation of the assay result. The ROC curve analysis is an alternative method to determine the status of patients since it correlates DNA analysis and G6PD activity.CONCLUSIONSThe establishment of the normal values for a population is important for a better evaluation of the assay result. The ROC curve analysis is an alternative method to determine the status of patients since it correlates DNA analysis and G6PD activity.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the commonest enzymopathy worldwide. The incidence depends essentially on the methods used for the assessment. In this respect, we attempted in this study to set cut-off values of G6PD activity to discriminate among normal, heterozygous, and deficient individuals using the World Health Organization (WHO) classification and the receiver operating characteristics (ROC) curve analysis. Methods: Blood samples from 250 female and 302 male subjects were enrolled in this study. The G6PD activity was determined using a quantitative assay. The common G6PD mutations in Tunisia were determined using the amplification refractory mutation system (ARMS-PCR) method. The ROC curve was used to choice the best cut-off. Results: Normal G6PD values were 7.69±2.37, 7.86±2.39, and 7.51±2.35 U/g Hb for the entire, male, and female groups, respectively. Cut-off values for the total, male, and female were determined using the WHO classification and ROC curves analysis. In the male population, both cut-offs established using ROC curve analysis (4.00 U/g Hb) and the 60% level (3.82 U/g Hb), respectively are sensitive and specific resulting in a good efficiency of discrimination between deficient and normal males. For the female group the ROC cut-off (5.84 U/g Hb) seems better than the 60% level cut-off (3.88 U/g Hb) to discriminate between normal and heterozygote or homozygote women with higher Youden Index. Conclusions: The establishment of the normal values for a population is important for a better evaluation of the assay result. The ROC curve analysis is an alternative method to determine the status of patients since it correlates DNA analysis and G6PD activity.
Author Fredj, Sondes Hadj
Toumi, Nourelhouda
Ouali, Faida
Daboubi, Rym
Laouini, Naouel
Siala, Hajer
Becher, Meriam
Bibi, Amina
Sahli, Chaima Abdelhafidh
Haloui, Sabrine
Jouini, Latifa
Messsaoud, Taieb
Author_xml – sequence: 1
  givenname: Naouel
  surname: Laouini
  fullname: Laouini, Naouel
  organization: Faculty of Sciences of Bizerte, University of Carthage, Tunis, Tunisia
– sequence: 2
  givenname: Chaima Abdelhafidh
  surname: Sahli
  fullname: Sahli, Chaima Abdelhafidh
  organization: Biochemistry Laboratory, Children’s Hospital, Research Laboratory LR0SP03, Tunis, Tunisia
– sequence: 3
  givenname: Latifa
  surname: Jouini
  fullname: Jouini, Latifa
  organization: Biochemistry Laboratory, Children’s Hospital, Research Laboratory LR0SP03, Tunis, Tunisia
– sequence: 4
  givenname: Sabrine
  surname: Haloui
  fullname: Haloui, Sabrine
  organization: Biochemistry Laboratory, Children’s Hospital, Research Laboratory LR0SP03, Tunis, Tunisia
– sequence: 5
  givenname: Sondes Hadj
  surname: Fredj
  fullname: Fredj, Sondes Hadj
  organization: Biochemistry Laboratory, Children’s Hospital, Research Laboratory LR0SP03, Tunis, Tunisia
– sequence: 6
  givenname: Rym
  surname: Daboubi
  fullname: Daboubi, Rym
  organization: Biochemistry Laboratory, Children’s Hospital, Research Laboratory LR0SP03, Tunis, Tunisia
– sequence: 7
  givenname: Hajer
  surname: Siala
  fullname: Siala, Hajer
  organization: Biochemistry Laboratory, Children’s Hospital, Research Laboratory LR0SP03, Tunis, Tunisia
– sequence: 8
  givenname: Faida
  surname: Ouali
  fullname: Ouali, Faida
  organization: Biochemistry Laboratory, Children’s Hospital, Research Laboratory LR0SP03, Tunis, Tunisia
– sequence: 9
  givenname: Meriam
  surname: Becher
  fullname: Becher, Meriam
  organization: Hematology Laboratory, Children’s Hospital, Tunis, Tunisia
– sequence: 10
  givenname: Nourelhouda
  surname: Toumi
  fullname: Toumi, Nourelhouda
  organization: Hematology Laboratory, Children’s Hospital, Tunis, Tunisia
– sequence: 11
  givenname: Amina
  surname: Bibi
  fullname: Bibi, Amina
  organization: Laboratory of Biology, National Institute of Nutrition and Food Technology, Tunis, Tunisia
– sequence: 12
  givenname: Taieb
  surname: Messsaoud
  fullname: Messsaoud, Taieb
  organization: Biochemistry Laboratory, Children’s Hospital, Research Laboratory LR0SP03, Tunis, Tunisia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28099116$$D View this record in MEDLINE/PubMed
BookMark eNp1kb1rHDEQxUWwiT-SNmVYSJNGtkZa7UeRIjhfBoObq9IInTS6W6OVNtKuw_330d3ZEExSzRS_93gz74KchBiQkHfArkCCvDbGj5QzaCjjUrwi51CLltZCwMlhr2nTcDgjFzk_MAZS1u1rcsY71vcAzTn5-QVnTOMQ9DzEUEVXbfxiYkba0Gkb87TVM1YWtzub4gaDzliZZabRuepR-wVzNYRKV6slDHnQoZritPiD2Rty6rTP-PZpXpLVt6-rmx_07v777c3nO2pqLmcKwmjTOYA1YqN7yZ11glsDrrXoYG0dcuGk6Lhj2oLrZWs7w3rbgkM04pJ8PNpOKf4qeWY1Dtmg9zpgXLKCrgHZtrWEgn54gT7EJYUSTkHPWfmJgL5Q75-oZT2iVVMaRp126vlpBaiPgEkx54ROmWE-nDwnPXgFTO27Uftu1L4bte-myK5eyJ6d_yv4dBT81r6UZHGTll1Z_kr9T6GUHZQ7xB841aZo
CitedBy_id crossref_primary_10_1038_s41598_017_17667_6
crossref_primary_10_1186_s12887_022_03740_1
crossref_primary_10_1093_ajcp_aqaa040
crossref_primary_10_1108_NFS_02_2021_0053
crossref_primary_10_3923_pjbs_2021_409_423
crossref_primary_10_5858_arpa_2021_0276_CP
crossref_primary_10_1016_j_jfma_2019_03_010
crossref_primary_10_4103_2305_0500_311609
Cites_doi 10.1016/j.bcmd.2008.12.005
10.1371/journal.pone.0028357
10.1136/jms.7.1.46
10.1186/1475-2875-12-391
10.1111/j.1365-2141.1979.tb03774.x
10.1002/j.1460-2075.1986.tb04436.x
10.1111/j.1651-2227.2002.tb03120.x
10.1002/j.1460-2075.1995.tb00205.x
10.1016/j.ymgme.2005.05.008
10.1053/j.semperi.2011.02.010
10.1016/j.patbio.2012.03.005
10.4269/ajtmh.14-0194
10.1371/journal.pmed.1001339
10.1016/S0140-6736(08)60073-2
10.1002/iub.137
10.1182/blood-2007-04-077412
10.1016/j.siny.2009.10.007
10.1371/journal.pntd.0004457
10.1007/s11033-012-2124-8
10.1016/j.bcmd.2012.01.001
10.1007/s00769-004-0878-y
ContentType Journal Article
Copyright Copyright Walter De Gruyter & Company 2017
Copyright_xml – notice: Copyright Walter De Gruyter & Company 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7T7
7TK
7U7
8FD
C1K
FR3
P64
7X8
DOI 10.1515/cclm-2016-0253
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Biotechnology Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Biotechnology Research Abstracts
Technology Research Database
Toxicology Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Biotechnology Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
EISSN 1437-4331
EndPage 1201
ExternalDocumentID 28099116
10_1515_cclm_2016_0253
10_1515_cclm_2016_02535581193
Genre Journal Article
GroupedDBID ---
0R~
0~D
29B
354
36B
4.4
53G
5GY
5RE
AAAEU
AABBZ
AAFPC
AAGVJ
AAILP
AALGR
AAONY
AAOQK
AAOWA
AAPJK
AAQCX
AARRE
AASQH
AAWFC
AAXCG
ABAOT
ABAQN
ABDRH
ABFKT
ABFQV
ABIQR
ABJNI
ABLJU
ABMIY
ABPLS
ABRDF
ABRQL
ABUVI
ABWLS
ABXMZ
ABYBW
ACDEB
ACEFL
ACGFS
ACIWK
ACMKP
ACPMA
ACPRK
ACUND
ACXLN
ACYCL
ACZBO
ADDWE
ADEQT
ADGQD
ADGYE
ADOZN
AECWL
AEDGQ
AEGVQ
AEICA
AEJTT
AEKEB
AENEX
AEQDQ
AERZL
AEXIE
AFBAA
AFBDD
AFBQV
AFCXV
AFGDO
AFGNR
AFQUK
AFRAH
AFYRI
AGBEV
AHOVO
AHVWV
AHXUK
AIERV
AIKXB
AIWOI
AJATJ
AJHHK
AKXKS
ALMA_UNASSIGNED_HOLDINGS
ALUKF
ALYBR
AMAVY
ASYPN
AZMOX
BAKPI
BBCWN
BCIFA
BWHEM
CGQUA
CS3
DU5
EBS
EJD
EMOBN
F5P
FSTRU
HZ~
IY9
KDIRW
N9A
O9-
OBC
OBS
OEB
OES
OHH
OVD
P2P
PQQKQ
QD8
RDG
SA.
SLJYH
TEORI
UK5
WTRAM
AAYXX
CITATION
ABVMU
CGR
CUY
CVF
DBYYV
ECM
EIF
NPM
7QO
7T7
7TK
7U7
8FD
C1K
FR3
P64
7X8
ID FETCH-LOGICAL-c425t-13cac8f11bee6a952fdf32dc1f7def1bdfe23f5382f0ad1f957d8c09d71feec3
ISSN 1434-6621
1437-4331
IngestDate Fri Jul 11 02:15:36 EDT 2025
Mon Jun 30 03:03:26 EDT 2025
Wed Feb 19 02:00:07 EST 2025
Thu Apr 24 23:03:47 EDT 2025
Tue Jul 01 02:49:27 EDT 2025
Thu Jul 10 10:38:19 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords glucose-6-phosphate dehydrogenase
G6PD
cut-off values
molecular diagnosis
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c425t-13cac8f11bee6a952fdf32dc1f7def1bdfe23f5382f0ad1f957d8c09d71feec3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 28099116
PQID 1920099319
PQPubID 105421
PageCount 9
ParticipantIDs proquest_miscellaneous_1861577451
proquest_journals_1920099319
pubmed_primary_28099116
crossref_citationtrail_10_1515_cclm_2016_0253
crossref_primary_10_1515_cclm_2016_0253
walterdegruyter_journals_10_1515_cclm_2016_02535581193
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-7-26
PublicationDateYYYYMMDD 2017-07-26
PublicationDate_xml – month: 07
  year: 2017
  text: 2017-7-26
  day: 26
PublicationDecade 2010
PublicationPlace Germany
PublicationPlace_xml – name: Germany
– name: Berlin
PublicationTitle Clinical chemistry and laboratory medicine
PublicationTitleAlternate Clin Chem Lab Med
PublicationYear 2017
Publisher De Gruyter
Walter De Gruyter & Company
Publisher_xml – name: De Gruyter
– name: Walter De Gruyter & Company
References (ref371) 2013; 40
(ref471) 2016; 10
(ref281) 2009; 42
(ref441) 2011; 35
(ref171) 2011; 35
(ref231) 2013; 12
(ref311) 2010
(ref491) 2011; 6
(ref341) 1986; 5
(ref411) 2009; 61
(ref291) 2012; 9
(ref71) 1986; 5
(ref391) 2016; 74
(ref361) 2012; 48
(ref211) 2010; 41
(ref331) 2010; 15
(ref121) 2016; 74
(ref191) 2005; 86
(ref501) 2013; 12
(ref381) 2013; 61
(ref21) 2012; 9
(ref461) 2005; 86
(ref111) 2013; 61
(ref51) 2008; 111
(ref321) 2008; 111
(ref531) 2000; 7
(ref201) 2016; 10
(ref181) 2014; 91
(ref101) 2013; 40
(ref61) 2010; 15
(ref261) 2000; 7
(ref81) 1998; 15
(ref241) 2004; 10
(ref431) 2005; 72
(ref481) 2010; 41
(ref131) 1979; 43
(ref151) 2010; 87
(ref521) 2002; 91
(ref401) 1979; 43
(ref271) 1995; 14
(ref41) 2010
(ref511) 2004; 10
(ref01) 1995; 14
(ref221) 2011; 6
(ref351) 1998; 15
(ref31) 2008; 371
(ref11) 2009; 42
(ref421) 2010; 87
(ref251) 2002; 91
(ref301) 2008; 371
(ref91) 2012; 48
(ref161) 2005; 72
(ref141) 2009; 61
(ref451) 2014; 91
References_xml – volume: 42
  start-page: 267
  year: 2009
  ident: ref281
  article-title: The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis
  publication-title: Blood Cells Mol Dis
  doi: 10.1016/j.bcmd.2008.12.005
– volume: 6
  start-page: e28357
  year: 2011
  ident: ref491
  article-title: Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0028357
– volume: 7
  start-page: 46
  year: 2000
  ident: ref531
  article-title: Glucose-6-phosphate dehydrogenase deficiency neonatal screening: preliminary evidence that a high percentage of partially deficient female neonates are missed during routine screening
  publication-title: J Med Screen
  doi: 10.1136/jms.7.1.46
– volume: 12
  start-page: 391
  year: 2013
  ident: ref501
  article-title: G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests
  publication-title: Malar J
  doi: 10.1186/1475-2875-12-391
– volume: 43
  start-page: 465
  year: 1979
  ident: ref401
  article-title: International Committee for Standardization in Haematology: Recommended screening test for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency
  publication-title: Br J Haematol
  doi: 10.1111/j.1365-2141.1979.tb03774.x
– volume: 41
  start-page: 982
  year: 2010
  ident: ref481
  article-title: G6PD enzyme activity in normal term Malaysian neonates and adults using a OSMMR2000-D kit with Hb normalization
  publication-title: Southeast Asian J Trop Med Public Health
– start-page: 4474
  volume-title: Oxford textbook of medicine
  year: 2010
  ident: ref41
– volume: 5
  start-page: 1849
  year: 1986
  ident: ref71
  article-title: Structural analysis of the X-linked gene encoding human glucose 6-phosphate dehydrogenase
  publication-title: EMBO J
  doi: 10.1002/j.1460-2075.1986.tb04436.x
– volume: 91
  start-page: 107
  year: 2002
  ident: ref251
  article-title: X-chromosome inactivation and human genetic disease
  publication-title: Acta Paediatr Suppl
  doi: 10.1111/j.1651-2227.2002.tb03120.x
– volume: 5
  start-page: 1849
  year: 1986
  ident: ref341
  article-title: Structural analysis of the X-linked gene encoding human glucose 6-phosphate dehydrogenase
  publication-title: EMBO J
  doi: 10.1002/j.1460-2075.1986.tb04436.x
– volume: 15
  start-page: 439
  year: 1998
  ident: ref351
  article-title: X chromosome inactivation patterns in normal females
  publication-title: Blood Cells Mol Dis
– volume: 87
  start-page: 69
  year: 2010
  ident: ref421
  article-title: Neonatal screening of G6PD deficiency in Tunisia
  publication-title: Arch Inst Pasteur Tunis
– volume: 14
  start-page: 5209
  year: 1995
  ident: ref271
  article-title: Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress
  publication-title: EMBO J
  doi: 10.1002/j.1460-2075.1995.tb00205.x
– volume: 86
  start-page: 212
  year: 2005
  ident: ref461
  article-title: Alternative DNA-based newborn screening for glucose-6-phosphate dehydrogenase deficiency
  publication-title: Mol Genet Metab
  doi: 10.1016/j.ymgme.2005.05.008
– volume: 14
  start-page: 5209
  year: 1995
  ident: ref01
  article-title: Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress
  publication-title: EMBO J
  doi: 10.1002/j.1460-2075.1995.tb00205.x
– volume: 35
  start-page: 155
  year: 2011
  ident: ref441
  article-title: Neonatal screening for glucose-6-phosphate dehydrogenase deficiency: biochemical versus genetic technologies
  publication-title: Semin Perinatol
  doi: 10.1053/j.semperi.2011.02.010
– volume: 74
  start-page: 219
  year: 2016
  ident: ref391
  article-title: Molecular identification of Gd A- and Gd B- G6PD deficient variants by ARMS-PCR in a Tunisian population
  publication-title: Ann Biol Clin
– volume: 7
  start-page: 46
  year: 2000
  ident: ref261
  article-title: Glucose-6-phosphate dehydrogenase deficiency neonatal screening: preliminary evidence that a high percentage of partially deficient female neonates are missed during routine screening
  publication-title: J Med Screen
  doi: 10.1136/jms.7.1.46
– volume: 61
  start-page: 64
  year: 2013
  ident: ref381
  article-title: Three new mutations account for the prevalence of glucose 6 phosphate deshydrogenase (G6PD) deficiency in Tunisia
  publication-title: Pathol Biol
  doi: 10.1016/j.patbio.2012.03.005
– volume: 87
  start-page: 69
  year: 2010
  ident: ref151
  article-title: Neonatal screening of G6PD deficiency in Tunisia
  publication-title: Arch Inst Pasteur Tunis
– volume: 35
  start-page: 155
  year: 2011
  ident: ref171
  article-title: Neonatal screening for glucose-6-phosphate dehydrogenase deficiency: biochemical versus genetic technologies
  publication-title: Semin Perinatol
  doi: 10.1053/j.semperi.2011.02.010
– volume: 91
  start-page: 854
  year: 2014
  ident: ref451
  article-title: Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency
  publication-title: Am J Trop Med Hyg
  doi: 10.4269/ajtmh.14-0194
– volume: 9
  start-page: e1001339
  year: 2012
  ident: ref21
  article-title: G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: A geostatistical model-based map
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.1001339
– volume: 6
  start-page: e28357
  year: 2011
  ident: ref221
  article-title: Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0028357
– volume: 9
  start-page: e1001339
  year: 2012
  ident: ref291
  article-title: G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: A geostatistical model-based map
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.1001339
– volume: 72
  start-page: 1277
  year: 2005
  ident: ref161
  article-title: Diagnosis and management of G6PD deficiency
  publication-title: Am Fam Physician
– volume: 15
  start-page: 439
  year: 1998
  ident: ref81
  article-title: X chromosome inactivation patterns in normal females
  publication-title: Blood Cells Mol Dis
– volume: 12
  start-page: 391
  year: 2013
  ident: ref231
  article-title: G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests
  publication-title: Malar J
  doi: 10.1186/1475-2875-12-391
– volume: 371
  start-page: 64
  year: 2008
  ident: ref31
  article-title: Glucose-6-phosphate dehydrogenase deficiency
  publication-title: Lancet
  doi: 10.1016/S0140-6736(08)60073-2
– volume: 61
  start-page: 27
  year: 2009
  ident: ref141
  article-title: Glucose-6-phosphate dehydrogenase laboratory assay: How, when, and why?
  publication-title: IUBMB Life
  doi: 10.1002/iub.137
– volume: 91
  start-page: 854
  year: 2014
  ident: ref181
  article-title: Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency
  publication-title: Am J Trop Med Hyg
  doi: 10.4269/ajtmh.14-0194
– volume: 42
  start-page: 267
  year: 2009
  ident: ref11
  article-title: The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis
  publication-title: Blood Cells Mol Dis
  doi: 10.1016/j.bcmd.2008.12.005
– volume: 111
  start-page: 16
  year: 2008
  ident: ref51
  article-title: Glucose-6-phosphate dehydrogenase deficiency: A historical perspective
  publication-title: Blood
  doi: 10.1182/blood-2007-04-077412
– volume: 15
  start-page: 148
  year: 2010
  ident: ref331
  article-title: Glucose-6-phosphate dehydrogenase deficiency and severe neonatal hyperbilirubinemia: A complexity of interactions between genes and environment
  publication-title: Semin Fetal Neonatal Med
  doi: 10.1016/j.siny.2009.10.007
– volume: 41
  start-page: 982
  year: 2010
  ident: ref211
  article-title: G6PD enzyme activity in normal term Malaysian neonates and adults using a OSMMR2000-D kit with Hb normalization
  publication-title: Southeast Asian J Trop Med Public Health
– volume: 74
  start-page: 219
  year: 2016
  ident: ref121
  article-title: Molecular identification of Gd A- and Gd B- G6PD deficient variants by ARMS-PCR in a Tunisian population
  publication-title: Ann Biol Clin
– volume: 10
  start-page: e0004457
  year: 2016
  ident: ref471
  article-title: Assessment of point-of-care diagnostics for G6PD deficiency in malaria endemic rural Eastern Indonesia
  publication-title: PLoS Neglected Tropical Diseases
  doi: 10.1371/journal.pntd.0004457
– volume: 61
  start-page: 64
  year: 2013
  ident: ref111
  article-title: Three new mutations account for the prevalence of glucose 6 phosphate deshydrogenase (G6PD) deficiency in Tunisia
  publication-title: Pathol Biol
  doi: 10.1016/j.patbio.2012.03.005
– volume: 91
  start-page: 107
  year: 2002
  ident: ref521
  article-title: X-chromosome inactivation and human genetic disease
  publication-title: Acta Paediatr Suppl
  doi: 10.1111/j.1651-2227.2002.tb03120.x
– volume: 72
  start-page: 1277
  year: 2005
  ident: ref431
  article-title: Diagnosis and management of G6PD deficiency
  publication-title: Am Fam Physician
– volume: 86
  start-page: 212
  year: 2005
  ident: ref191
  article-title: Alternative DNA-based newborn screening for glucose-6-phosphate dehydrogenase deficiency
  publication-title: Mol Genet Metab
  doi: 10.1016/j.ymgme.2005.05.008
– volume: 371
  start-page: 64
  year: 2008
  ident: ref301
  article-title: Glucose-6-phosphate dehydrogenase deficiency
  publication-title: Lancet
  doi: 10.1016/S0140-6736(08)60073-2
– volume: 61
  start-page: 27
  year: 2009
  ident: ref411
  article-title: Glucose-6-phosphate dehydrogenase laboratory assay: How, when, and why?
  publication-title: IUBMB Life
  doi: 10.1002/iub.137
– volume: 43
  start-page: 465
  year: 1979
  ident: ref131
  article-title: International Committee for Standardization in Haematology: Recommended screening test for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency
  publication-title: Br J Haematol
  doi: 10.1111/j.1365-2141.1979.tb03774.x
– volume: 111
  start-page: 16
  year: 2008
  ident: ref321
  article-title: Glucose-6-phosphate dehydrogenase deficiency: A historical perspective
  publication-title: Blood
  doi: 10.1182/blood-2007-04-077412
– volume: 40
  start-page: 851
  year: 2013
  ident: ref101
  article-title: Glucose-6-phosphate dehydrogenase deficiency in Tunisia: molecular data and phenotype-genotype association
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-012-2124-8
– volume: 48
  start-page: 154
  year: 2012
  ident: ref361
  article-title: Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the “old” and update of the new mutations
  publication-title: Blood Cells Mol Dis
  doi: 10.1016/j.bcmd.2012.01.001
– volume: 10
  start-page: 27
  year: 2004
  ident: ref511
  article-title: Performance evaluation of a G-6-PD assay employing an adapted error grid graph
  publication-title: Accred Qual Assur
  doi: 10.1007/s00769-004-0878-y
– volume: 40
  start-page: 851
  year: 2013
  ident: ref371
  article-title: Glucose-6-phosphate dehydrogenase deficiency in Tunisia: molecular data and phenotype-genotype association
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-012-2124-8
– volume: 15
  start-page: 148
  year: 2010
  ident: ref61
  article-title: Glucose-6-phosphate dehydrogenase deficiency and severe neonatal hyperbilirubinemia: A complexity of interactions between genes and environment
  publication-title: Semin Fetal Neonatal Med
  doi: 10.1016/j.siny.2009.10.007
– volume: 48
  start-page: 154
  year: 2012
  ident: ref91
  article-title: Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the “old” and update of the new mutations
  publication-title: Blood Cells Mol Dis
  doi: 10.1016/j.bcmd.2012.01.001
– volume: 10
  start-page: e0004457
  year: 2016
  ident: ref201
  article-title: Assessment of point-of-care diagnostics for G6PD deficiency in malaria endemic rural Eastern Indonesia
  publication-title: PLoS Neglected Tropical Diseases
  doi: 10.1371/journal.pntd.0004457
– volume: 10
  start-page: 27
  year: 2004
  ident: ref241
  article-title: Performance evaluation of a G-6-PD assay employing an adapted error grid graph
  publication-title: Accred Qual Assur
  doi: 10.1007/s00769-004-0878-y
– start-page: 4474
  volume-title: Oxford textbook of medicine
  year: 2010
  ident: ref311
SSID ssj0015547
Score 2.2341673
Snippet Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the commonest enzymopathy worldwide. The incidence depends essentially on the methods used for the...
SourceID proquest
pubmed
crossref
walterdegruyter
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1193
SubjectTerms Adolescent
Adult
Blood Chemical Analysis - standards
Child
Classification
Correlation analysis
cut-off values
Dehydrogenase
Dehydrogenases
Deoxyribonucleic acid
DNA
Female
G6PD
Genotype
Glucose
Glucose 6 phosphate dehydrogenase
Glucosephosphate dehydrogenase
Glucosephosphate Dehydrogenase - blood
Glucosephosphate Dehydrogenase - genetics
Glucosephosphate Dehydrogenase Deficiency - blood
Glucosephosphate Dehydrogenase Deficiency - genetics
Heterozygote
Humans
Incidence
Male
Males
molecular diagnosis
Mutation
Phosphates
Polymerase chain reaction
Reference Values
Sampling methods
Tunisia
Young Adult
Title Determination of glucose-6-phosphate dehydrogenase cut-off values in a Tunisian population
URI https://www.degruyter.com/doi/10.1515/cclm-2016-0253
https://www.ncbi.nlm.nih.gov/pubmed/28099116
https://www.proquest.com/docview/1920099319
https://www.proquest.com/docview/1861577451
Volume 55
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZKJ8F4mGBcVhjISEg8VIY49zyWMpimjRcKmniJfKWV2qbqEqHxwl_nOLHTyzoJeImqxLWjfJ-Pz_G5GKHXPJWw6saMJJEOSJj4gmRMeMTjGWe-hkUwNNnIF5_j06_h2WV02en8Xotaqkr-VvzamVfyP6jCPcDVZMn-A7Jtp3ADfgO-cAWE4fpXGH9wsSxO7bMB6CQmi3FxtRiDItmXanwtlwV0wkxoelWSQuu-KfJdx2L1WX9kXNpmoi_a07zWddahS54U7nC42uNg6WN89NsO-nNWVJP6rCiQ3kWl2iiOL2zcpGMPx2wyY_0Bl8Zjryey3ZU-a_96Dm-i2UpETuFJs4nNl24wu19B641Q31a7bmRsGCSrRC0rhJtavZZs6ZpEpbQ5QfGGqI_qqhhCTGfACWoiqaONhgDVYlYD76egBlO6VXG7XsPdoztozwc7w--ivcGn9yffWkcUaFuJrfUJA77bHM5UkrYdbKo1N2yV--jgZx3-INWPZXVdOnd7rcWMHqADa37gQcOlh6ij5ofo3tABe4juXlgsH6HvG_TChcY76IU36IUtvXBDLzyZY4YdvfCKXo_R6OPJaHhK7FEcRIBQLwkNBBOpppQrFbMs8rXUgS8F1YlUmnKplR9oWDxhejNJdRYlMhVeJhOqlRLBE9SdF3N1hLAnMxOHJX2ZsjDzQs55FkcyTWFpYZ7WPUTch8yFLVNvTkuZ5sZcBQxyg0FuMMgNBj30pm2_aAq03Nry2OGS20l8lYOBY4wkWIh66FX7GL658ZuxuSoqaJOC2g9mUkR76GmDZzuUw7-H4i2A18bY-TpRlBpuP7u1y-dofzV_jlG3XFbqBWjAJX9pWfoHIEu1zA
linkProvider Walter de Gruyter
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwED5BJ7HxMGAMCAwwEhJPXmMncZLHMTYKrHsqaOIl8k860SVVmwiNv57zkkZlgxd4jhPbd2d_n3PnO4DXKjOIukLSNHERjVOuaS51SEOVK8kdgmDsbyOPT8Xoc_zxLDlbuwvjwyqN_bZoLus2Q-rQVLrxP8r6XAOIwEOtZxeoYOYDaJNoOK0vZrdhI4vxvDKAjYP3b4--9L4EBMyrEitxFFMhOOtSN978zO_QdINv3oXtH1cu7H58a0h0fA_0ag5tAMr3_aZW-_rntfSO_zfJ-7DdEVVy0FrWA7hlyx3YPFzVh9uBO-POLf8Qvr5bBdV4NZPKkS4Sngo6n1bL-RQZLTF2emkWFVosIifRTU0r54jPNm6X5Lwkkky8bx3tlcz7smK7MDk-mhyOaFe0gWpc_r60vZY6c4wpa4XME-6Mi7jRzKXGOqaMszxyuM2iIUjDXJ6kJtNhblLmrNXRIxiUVWmfAAlN7iN2DDeZjPMwVkrlIjF4ZI-4DJ0LgK7UVeguobmvqzEr_MEGBVh4ARZegIUXYABv-vbzNpXHX1vurbRfdEt6WSAV9nQat6wAXvWPUebewyJLWzXYJkOCiIQ6YQE8bq2m74pn-DZjIgBxzYzW-vjjcJIkY8izn_7riy9hczQZnxQnH04_PYMt7olJmFIu9mBQLxr7HGlVrV506-YXTP0fZA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7BVipwKFBegQJGQuLkbuwkTnIsbZfyaMVhQYhL5CdbtSTRbiJUfj3j5qHSwgXOsWN7Zuz5nPkyA_BSZQa9rpA0TVxE45Rrmksd0lDlSnKHTjD2fyMfHomDT_G7L8nAJlz1tEpjvy3bs6bLkDo1lW79h7Ix1wB64KnWp99RwcwTaJNoWht3HdayGO8yE1jbefN6__MYSkB_eV5hJY5iKgRnfebGq2_53TNdgZu3YOPHeQR7nN4FRzS7DWpYQsc_OdluG7Wtf17K7vhfa7wDGz1MJTudXd2Fa7bchBu7Q3W4TVg_7IPy9-Dr3kCp8UomlSM9D54KWi-qVb1APEuMXZyZZYX2in6T6LahlXPE5xq3K3JcEknmPrKO1krqsajYfZjP9ue7B7Qv2UA1bn5f2F5LnTnGlLVC5gl3xkXcaOZSYx1TxlkeOTxk0QykYS5PUpPpMDcpc9bq6AFMyqq0j4CEJvd8HcNNJuM8jJVSuUgMXtgjLkPnAqCDtgrdpzP3VTVOC3-tQfkVXn6Fl1_h5RfAq7F93SXy-GvLrUH5Rb-hVwUCYQ-m8cAK4MX4GGXu4yuytFWLbTKEhwinExbAw85oxqF4hr0ZEwGIS1Z0YYw_TidJMoYo-_G_dnwO6x_3ZsWHt0fvn8BN7lFJmFIutmDSLFv7FDFVo571u-YX1KAeCw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Determination+of+glucose-6-phosphate+dehydrogenase+cut-off+values+in+a+Tunisian+population&rft.jtitle=Clinical+chemistry+and+laboratory+medicine&rft.au=Laouini%2C+Naouel&rft.au=Sahli%2C+Chaima+Abdelhafidh&rft.au=Jouini%2C+Latifa&rft.au=Haloui%2C+Sabrine&rft.date=2017-07-26&rft.eissn=1437-4331&rft.volume=55&rft.issue=8&rft.spage=1193&rft_id=info:doi/10.1515%2Fcclm-2016-0253&rft_id=info%3Apmid%2F28099116&rft.externalDocID=28099116
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1434-6621&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1434-6621&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1434-6621&client=summon